Astellas Pharma Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2830 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas - Jun 23rd, 2026 6:05 am
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Jun 22nd, 2026 7:40 am
Is Astellas Pharma (ALPMY) Stock Undervalued Right Now? - Jun 22nd, 2026 7:40 am
Astellas Pharma (TSE:4503) Stock Valuation After KRAS Trial Progress And AI Overhaul - Jun 13th, 2026 10:11 am
Astellas taps AI to reshape clinical programs as rising stars emerge - Jun 12th, 2026 3:21 am
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026? - Jun 11th, 2026 7:38 am
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Jun 5th, 2026 7:40 am
Is Astellas Pharma (ALPMY) a Great Value Stock Right Now? - Jun 5th, 2026 7:40 am
Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data? - Jun 3rd, 2026 9:39 am
Astellas Board Change Raises Questions On R&D Oversight And Governance - Jun 3rd, 2026 4:07 am
Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine - May 26th, 2026 4:16 am
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company - May 26th, 2026 12:45 am
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer - May 25th, 2026 10:25 am
Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony. - May 22nd, 2026 3:20 pm
Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals - May 21st, 2026 5:29 am
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion - May 18th, 2026 9:34 am
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 - May 18th, 2026 6:00 am
Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche - May 13th, 2026 7:24 am
Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo - May 13th, 2026 7:19 am
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients - May 12th, 2026 7:00 am